Medicare Enrolled

Dr. Ibrahim Sadek, M.D.

Medical Oncology · The Villages, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2955 BROWNWOOD BLVD STE 107, The Villages, FL 32163
3527657100
In practice since 2010 (15 years)
NPI: 1457672685 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sadek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sadek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sadek

Dr. Ibrahim Sadek is a medical oncology in The Villages, FL, with 15 years in practice. Based on federal Medicare data, Dr. Sadek performed 143,346 Medicare services across 3,886 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sadek received a total of $9,720 from 65 pharmaceutical and/or device companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sadek is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 18% volume in FL$ $9,720 industry payments

Medicare Practice Summary

Medicare Utilization ↗
143,346
Medicare services
Top 18% in FL for medical oncology
3,886
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,556 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)73,440$0$4
Iron sucrose injection (Venofer)19,000$0$5
Filgrastim injection (Zarxio) for white blood cells10,860$0$2
Pembrolizumab injection (Keytruda)7,600$44$137
Anti-nausea injection (aprepitant)6,890$1$5
Denosumab injection (Prolia/Xgeva)5,760$19$51
Iron infusion (Monoferric)4,500$16$57
Epoetin alfa injection (Procrit) for anemia3,240$6$23
Dexamethasone injection (steroid)2,014$0$3
Blood draw (venipuncture)1,441$8$9
Complete blood count (CBC) with differential1,429$8$29
Drug injection, under skin or into muscle1,056$10$69
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg794$1$6
Anti-nausea injection (Aloxi/palonosetron)780$1$28
Anti-nausea injection (ondansetron/Zofran)696$0$9
Office visit, established patient (30-39 min)436$97$339
Injection of additional new drug or substance into vein405$12$61
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less373$48$189
Administration of chemotherapy into vein, 1 hour or less301$97$378
Initial hospital admission, high complexity269$137$556
Office visit, established patient, complex (40-54 min)251$134$474
Infusion into a vein for hydration, each additional hour199$10$42
Injection, magnesium sulfate, per 500 mg146$1$2
Injection, diphenhydramine hcl, up to 50 mg125$1$3
Injection of drug or substance into vein122$27$156
Administration of chemotherapy into vein, each additional hour122$21$79
Hospital follow-up visit, high complexity119$93$285
Infusion, normal saline solution , 1000 cc119$2$7
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour118$16$56
Office visit, established patient (20-29 min)104$65$239
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle101$54$206
New patient office visit, complex (60-74 min)83$161$585
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less73$21$84
Administration of additional new drug or substance into vein, 1 hour or less59$49$178
New patient office visit (45-59 min)56$124$453
Injection, methylprednisolone sodium succinate, up to 40 mg52$3$11
Infusion into a vein for hydration, 31-60 minutes46$23$156
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional45$16$59
Biopsy and aspiration of bone marrow sample for diagnosis37$132$467
Automated urinalysis29$2$8
Infusion, normal saline solution, sterile (500 ml = 1 unit)26$1$7
Red blood count automated, with additional calculations15$5$20
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle15$24$89
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.0% high complexity
41.9% medium
3.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,720
Total received (2021-2024)
Avg $2,430/year across 4 years
Top 44% in FL for medical oncology
65
Companies
433
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,557 (88.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$663 (6.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$500 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,895
2023
$3,529
2022
$1,778
2021
$517

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$659
EMD Serono, Inc.
$609
Seagen Inc.
$570
Merck Sharp & Dohme LLC
$567
Celgene Corporation
$552
Incyte Corporation
$510
E.R. Squibb & Sons, L.L.C.
$441
Novartis Pharmaceuticals Corporation
$435
PFIZER INC.
$407
Astellas Pharma US Inc
$283
Lilly USA, LLC
$268
Eisai Inc.
$254
Daiichi Sankyo Inc.
$228
Genentech USA, Inc.
$215
Kite Pharma, Inc.
$206
GENZYME CORPORATION
$194
Amgen Inc.
$169
CTI BioPharma Corp.
$165
ADC Therapeutics America, Inc.
$162
Gilead Sciences, Inc.
$161
Regeneron Healthcare Solutions, Inc.
$154
ABBVIE INC.
$153
Pharmacyclics LLC, An AbbVie Company
$151
BeiGene USA, Inc.
$149
Janssen Biotech, Inc.
$138
Alexion Pharmaceuticals, Inc.
$138
JAZZ PHARMACEUTICALS INC.
$136
Takeda Pharmaceuticals U.S.A., Inc.
$130
GlaxoSmithKline, LLC.
$119
G1 Therapeutics, Inc.
$100
Tempus AI, Inc
$88
Ipsen Biopharmaceuticals, Inc
$86
Pharmacosmos Therapeutics Inc.
$84
PharmaEssentia USA Corporation
$77
Bayer Healthcare Pharmaceuticals Inc.
$59
SERVIER PHARMACEUTICALS LLC
$56
TAIHO ONCOLOGY, INC.
$51
Puma Biotechnology, Inc.
$50
TerSera Therapeutics LLC
$49
ARRAY BIOPHARMA INC
$48
SOBI, INC
$48
Foundation Medicine, Inc.
$46
AbbVie Inc.
$44
EISAI INC.
$44
Stemline Therapeutics Inc.
$39
Apellis Pharmaceuticals, Inc.
$32
Karyopharm Therapeutics Inc.
$31
Spectrum Pharmaceuticals Inc.
$28
Rigel Pharmaceuticals, Inc.
$26
Agios Pharmaceuticals, Inc.
$25
Aveo Pharmaceuticals, Inc.
$23
Tolmar, Inc.
$23
Telix Pharmaceuticals
$23
PUMA BIOTECHNOLOGY, INC.
$23
MorphoSys, US Inc.
$22
Myriad Genetic Laboratories, Inc.
$21
EUSA Pharma (US) LLC
$20
Genmab U.S., Inc.
$19
Sobi, Inc
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Merck Sharp & Dohme Corporation
$17
Global Blood Therapeutics, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Kyowa Kirin, Inc.
$14
Top 3 companies account for 18.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · Alecensa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CALQUENCE · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · GILOTRIF · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Polivy · Pomalyst · Poteligeo · Quzyttir · REBLOZYL · ROLVEDON · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Stivarga · Sylvant · TAFINLAR · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tepmetko · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XPOVIO · XT CDX · XTANDI · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a medical oncology in The Villages?
Compare medical oncologys in the The Villages area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
8
Per 100K population
5.8
County median income
$73,297
Nearest hospital
UF HEALTH LEESBURG HOSPITAL
6.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sadek is a mixed practice specialist, with above-average Medicare volume (top 18% in FL), and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sadek experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sadek performed 73,440 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sadek receive payments from pharmaceutical companies?
Yes. Dr. Sadek received a total of $9,720 from 65 companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sadek's costs compare to other medical oncologys in The Villages?
Dr. Sadek's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sadek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →